Assignee
RXI PHARMACEUTICALS CORP
US·6 granted patents·8 pending applications·217 citations·filing 2007–2016
Top patents by PatentIndex Score
14 records- 0198US9938530B2RNA interference in skin indicationsRXI PHARMACEUTICALS CORP·Filed 2016·Granted Apr 10, 2018·25 cites·19 claims
- 0298US9303259B2RNA interference in skin indicationsRXI PHARMACEUTICALS CORP·Filed 2013·Granted Apr 5, 2016·46 cites·12 claims
- 0398US9175289B2Reduced size self-delivering RNAi compoundsRXI PHARMACEUTICALS CORP·Filed 2014·Granted Nov 3, 2015·80 cites·17 claims
- 0497US10167471B2Inhibition of PCSK9 through RNAIRXI PHARMACEUTICALS CORP·Filed 2016·Granted Jan 1, 2019·20 cites·11 claims
- 0596US10184124B2RNA interference in ocular indicationsRXI PHARMACEUTICALS CORP·Filed 2015·Granted Jan 22, 2019·23 cites·14 claims
- 0696US9963702B2RNA interference in dermal and fibrotic indicationsRXI PHARMACEUTICALS CORP·Filed 2016·Granted May 8, 2018·23 cites·20 claims
- 0756US2015105448A1Means and methods for the specific modulation of target genes in the cns and the eye and methods for their identificationRXI PHARMACEUTICALS CORP·Filed 2014·Application pending·0 cites
- 0855US2011251258A1Rnai constructs and uses thereofRXI PHARMACEUTICALS CORP·Filed 2009·Application pending·0 cites
- 0953US2009131360A1Tripartite RNAi constructsRXI PHARMACEUTICALS CORP·Filed 2008·Application pending·0 cites
- 1048US2010069620A1Novel compositions of chemically modified small interfering rnaRXI PHARMACEUTICALS CORP·Filed 2007·Application pending·0 cites
- 1146US2016304875A1Methods for treatment of wound healing utilizing chemically modified oligonucleotidesRXI PHARMACEUTICALS CORP·Filed 2014·Application pending·0 cites
- 1243US2019029974A1Methods for treating skin disorders and conditions utilizing haptensRXI PHARMACEUTICALS CORP·Filed 2016·Application pending·0 cites
- 1339US2018263925A1Methods for the treatment of alopecia areata utilizing gene modulation approachesRXI PHARMACEUTICALS CORP·Filed 2015·Application pending·0 cites
- 1433US2017051290A1Methods for treatment of disorders in the front of the eye utilizing nucleic acid moleculesRXI PHARMACEUTICALS CORP·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when RXI PHARMACEUTICALS CORP files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →